HIV Capsid Inhibitor Capacity of Different Isomers of Di-Pyridine Benzene and Its Alkyl and Halide Derivatives

21 October 2019, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


HIV-1 Capsid-A inhibitor capacity of different isomers of di-pyridine benzene and its alkyl and halide derivatives are studied systematically. It is found that p-di-pyridine o-ethyl benzene has very good inhibition constant. It is a small, cost effective organic compound and very promising as a HIV drug. It is a molecular docking based study.


Molecular docking modeling
HIV drug
Capsid-A inhibitor
p-di-pyridine benzene


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.